Safety of Everolimus in Patients Younger than 3 Years of Age: Results from EXIST-1, a Randomized, Controlled Clinical Trial.
about
Profile of everolimus in the treatment of tuberous sclerosis complex: an evidence-based review of its place in therapymTOR inhibitors in the pharmacologic management of tuberous sclerosis complex and their potential role in other rare neurodevelopmental disorders.Progress report on new antiepileptic drugs: A summary of the Thirteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIII).Presentation and Diagnosis of Tuberous Sclerosis Complex in Infants.
P2860
Safety of Everolimus in Patients Younger than 3 Years of Age: Results from EXIST-1, a Randomized, Controlled Clinical Trial.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Safety of Everolimus in Patien ...... ed, Controlled Clinical Trial.
@en
type
label
Safety of Everolimus in Patien ...... ed, Controlled Clinical Trial.
@en
prefLabel
Safety of Everolimus in Patien ...... ed, Controlled Clinical Trial.
@en
P2093
P1476
Safety of Everolimus in Patien ...... zed, Controlled Clinical Trial
@en
P2093
David Neal Franz
Noah Berkowitz
Thomas Brechenmacher
P304
151-155.e1
P356
10.1016/J.JPEDS.2016.01.027
P407
P577
2016-02-06T00:00:00Z